3rd Quarter - Amendment

AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION for AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION

Firm
Client
Income
—
Expenses
$306,918
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 18, 2013 $306,918 Replaced
3rd Quarter - Amendment (this page) Jan 22, 2015 $306,918 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Lobby in support of FDA examination of the current classification of indoor tanning beds. Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013).Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus

LobbyistCovered position, as disclosed
SHAWN FRIESEN —
KATIE JONES —
CHRISTINE O'CONNOR —
WHITNEY TYLER —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 959 (113th), H.R. 2817 (113th), H.R. 1427 (113th), H.R. 460 (113th), H.R. 3204 (113th)

Medicare/Medicaid MMM

Support legislation to eliminate the Independent Payment Advisory Board (S.351, H.R. 351, Protecting Seniors' Access to Medicare Act of 2013). Support legislation to increase residency slots for Graduate Medical Education (H.R. 1201, Training Tomorrow's Doctors Today Act).Lobby Congress on enacting a permanent repeal to the Medicare sustainable growth rate (H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013). Lobby Congress in opposition to proposed legislation to repeal in-office ancillary and physician services for anatomic pathology services (H.R. 2914, Promoting Integrity in Medicare Act of 2013). Lobby Congress on impact of Health Information Technology. Support legislation to reform the Medicare and Medicaid Electronic Health Records Incentive Program (H.R. 1331, Electronic Health Records Improvement Act). Lobby Congress on provisions to stop cuts in Medicare physician payments. Lobby Congress to oppose cuts to reimbursement for phototherapy services furnished in an office or other non-facility setting.

LobbyistCovered position, as disclosed
SHAWN FRIESEN —
KATIE JONES —
CHRISTINE O'CONNOR —
WHITNEY TYLER —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 351 (113th), H.R. 1331 (113th), H.R. 1201 (113th), H.R. 2810 (113th), H.R. 351 (113th), H.R. 2914 (113th)

Medical/Disease Research/Clinical Labs MED

Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, and Centers for Disease Control and Prevention

LobbyistCovered position, as disclosed
SHAWN FRIESEN —
KATIE JONES —
CHRISTINE O'CONNOR —
WHITNEY TYLER —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Torts TOR

Advocate for legislation to enact medical liablity reform Support inclusion of the Standard of Care Protection Act (H.R. 1473) in H.R. 2810

LobbyistCovered position, as disclosed
SHAWN FRIESEN —
KATIE JONES —
CHRISTINE O'CONNOR —
WHITNEY TYLER —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2810 (113th), H.R. 1473 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.